Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial

被引：0
作者：
Scarfo, Lydia [1 ,2 ,3 ]
Ferrari, Silvia [4 ]
Frustaci, Anna Maria [5 ]
Tani, Monica [6 ]
Bari, Alessia [7 ]
Scarano, Eloise [1 ,2 ]
Colia, Maria [1 ,2 ]
Ranghetti, Pamela [3 ]
Angelillo, Piera [8 ]
Ronchi, Paola [9 ]
Ponzoni, Maurilio [1 ,10 ]
Ferreri, Andres J. M. [8 ]
Ghia, Paolo [1 ,2 ,3 ]
机构：
[1] Osped San Raffaele, Ist Ricovero Cura & Carattere Sci IRCCS, Strateg Res Program Chron Lymphat Leukemia CLL, Via Olgettina 58, I-20132 Milan, Italy
[2] Univ Vita Salute San Raffaele, Via Olgettina 58, I-20132 Milan, Italy
[3] IRCCS Osped San Raffaele, B Cell Neoplasia Unit, Milan, Italy
[4] Azienda Socio Sanit Terr ASST Papa Giovanni XXIII, Hematol & Bone Marrow Transplant Unit, Bergamo, Italy
[5] Azienda Socio Sanit Terr ASST Grande Osped Metrop, Dept Haematol, Niguarda Canc Ctr, Milan, Italy
[6] Santa Maria Croci Hosp, Hematol, Ravenna, Italy
[7] Univ Modena & Reggio Emilia, Dipartimento Sci Med & Chirurg Materno Infantili, Modena, Italy
[8] Osped San Raffaele, Ist Ricovero & Cura Carattere Sci IRCCS, Lymphoma Unit, Milan, Italy
[9] Ist Ricovero & Cura Carattere Sci IRCCS Osped San, Immunohematol & Transfus Med Unit, Milan, Italy
[10] Osped San Raffaele, Ist Ricovero & Cura Carattere Sci IRCCS, Milan, Italy
来源：
BLOOD ADVANCES | 2022年 / 6卷 / 18期
关键词：
BRUTON TYROSINE KINASE; RITUXIMAB MONOTHERAPY; INHIBITION; RESPONSES; IBRUTINIB;
D O I：
10.1182/bloodadvances.2022007138
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5356 / 5359
页数：4
相关论文
共 18 条
  • [1] Splenic marginal zone lymphoma: from genetics to management
    Arcaini, Luca
    Rossi, Davide
    Paulli, Marco
    [J]. BLOOD, 2016, 127 (17) : 2072 - 2081
  • [2] Bennett M, 2005, HAEMATOLOGICA, V90, P856
  • [3] Marginal Zone Lymphomas
    Bertoni, Francesco
    Rossi, Davide
    Raderer, Markus
    Zucca, Emanuele
    [J]. CANCER JOURNAL, 2020, 26 (04) : 336 - 347
  • [4] Revised response criteria for malignant lymphoma
    Cheson, Bruce D.
    Pfistner, Beate
    Juweid, Malik E.
    Gascoyne, Randy D.
    Specht, Lena
    Horning, Sandra J.
    Coiffier, Bertrand
    Fisher, Richard I.
    Hagenbeek, Anton
    Zucca, Emanuele
    Rosen, Steven T.
    Stroobants, Sigrid
    Lister, T. Andrew
    Hoppe, Richard T.
    Dreyling, Martin
    Tobinai, Kensei
    Vose, Julie M.
    Connors, Joseph M.
    Federico, Massimo
    Diehl, Volker
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) : 579 - 586
  • [5] Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma
    Dreyling, Martin
    Santoro, Armando
    Mollica, Luigina
    Leppa, Sirpa
    Follows, George A.
    Lenz, Georg
    Kim, Won Seog
    Nagler, Arnon
    Panayiotidis, Panayiotis
    Demeter, Judit
    Ozcan, Muhit
    Kosinova, Marina
    Bouabdallah, Krimo
    Morschhauser, Franck
    Stevens, Don A.
    Trevarthen, David
    Giurescu, Marius
    Cupit, Lisa
    Liu, Li
    Koechert, Karl
    Seidel, Henrik
    Pena, Carol
    Yin, Shuxin
    Hiemeyer, Florian
    Garcia-Vargas, Jose
    Childs, Barrett H.
    Zinzani, Pier Luigi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (35) : 3898 - +
  • [6] Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma
    Fowler, Nathan H.
    Samaniego, Felipe
    Jurczak, Wojciech
    Ghosh, Nilanjan
    Derenzini, Enrico
    Reeves, James A.
    Knopinska-Posluszny, Wanda
    Cheah, Chan Y.
    Phillips, Tycel
    Lech-Maranda, Ewa
    Cheson, Bruce D.
    Caimi, Paolo F.
    Grosicki, Sebastian
    Leslie, Lori A.
    Chavez, Julio C.
    Fonseca, Gustavo
    Babu, Sunil
    Hodson, Daniel J.
    Shao, Spencer H.
    Burke, John M.
    Sharman, Jeff P.
    Law, Jennie Y.
    Pagel, John M.
    Miskin, Hari P.
    Sportelli, Peter
    O'Connor, Owen A.
    Weiss, Michael S.
    Zinzani, Pier Luigi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15) : 1609 - +
  • [7] PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
    Gopal, Ajay K.
    Kahl, Brad S.
    de Vos, Sven
    Wagner-Johnston, Nina D.
    Schuster, Stephen J.
    Jurczak, Wojciech J.
    Flinn, Ian W.
    Flowers, Christopher R.
    Martin, Peter
    Viardot, Andreas
    Blum, Kristie A.
    Goy, Andre H.
    Davies, Andrew J.
    Zinzani, Pier Luigi
    Dreyling, Martin
    Johnson, Dave
    Miller, Langdon L.
    Holes, Leanne
    Li, Daniel
    Dansey, Roger D.
    Godfrey, Wayne R.
    Salles, Gilles A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (11) : 1008 - 1018
  • [8] First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial
    Hagenbeek, Anton
    Gadeberg, Ole
    Johnson, Peter
    Pedersen, Lars Moller
    Walewski, Jan
    Hellmann, Andrzej
    Link, Brian K.
    Robak, Tadeusz
    Wojtukiewicz, Marek
    Pfreundschuh, Michael
    Kneba, Michael
    Engert, Andreas
    Sonneveld, Pieter
    Flensburg, Mimi
    Petersen, Jorgen
    Losic, Nedjad
    Radford, John
    [J]. BLOOD, 2008, 111 (12) : 5486 - 5495
  • [9] Rituximab monotherapy is highly effective in splenic marginal zone lymphoma
    Kalpadakis, C.
    Pangalis, G. A.
    Dimopoulou, M. N.
    Vassilakopoulos, T. P.
    Kyrtsonis, M-C
    Korkolopoulou, P.
    Kontopidou, F. N.
    Siakantaris, M. P.
    Dimitriadou, E. M.
    Kokoris, S. I.
    Tsaftaridis, P.
    Plata, E.
    Angelopoulou, M. K.
    [J]. HEMATOLOGICAL ONCOLOGY, 2007, 25 (03) : 127 - 131
  • [10] Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance
    Kalpadakis, Christina
    Pangalis, Gerassimos A.
    Sachanas, Sotirios
    Tsirkinidis, Pantelis
    Kontopidou, Flora N.
    Moschogiannis, Maria
    Yiakoumis, Xanthi
    Koulieris, Efstathios
    Dimopoulou, Maria N.
    Kokkoris, Stella I.
    Kyrtsonis, Marie-Christine
    Siakantaris, Marina P.
    Tsourouflis, Gerassimos
    Korkolopoulou, Penelope
    Rontogianni, Dimitra
    Tsaftaridis, Panagiotis
    Plata, Eleni
    Papadaki, Helen A.
    Panagiotidis, Panagiotis
    Angelopoulou, Maria K.
    Vassilakopoulos, Theodoros P.
    [J]. BLOOD, 2018, 132 (06) : 666 - +
12